01 January 2001
Detection of etiological agent for cholera by PCR protocol.
Atya Kapley, Hemant J PurohitMed Sci Monit 2001; 7(2): CR242-245 :: ID: 421155
Abstract
BACKGROUND: PCR protocol for Vibrio cholerae, the causative agent of thediarrheal disease cholera has been described in this report. We report the detection of Vibrio speciesin drinking water samples in a duplex PCR reaction. The target loci used in the study were ctxA and tcpA.The sensitivity and efficiency of detection of this protocol can be applied in epidemic conditions, whereinmonitoring of target organisms is very crucial.
MATERIAL AND METHODS: Single step thermocycling programshave been reported for amplification of specific target loci. We have demonstrated that a gradient multi-stepthermocycling program is more efficient in improving the sensitivity of detection by PCR. The methodfor preparation of template DNA from environmental sample uses filtration of water followed by harvestingthe possible bacterial residue. This was further treated with proteinase K and heat to yield DNA compatiblefor PCR. The protocol was optimized for amplification of target loci from standard strains as well asfrom environmental water samples.
RESULTS: The method can simultaneously detect two different loci ofVibrio cholerae in a single reaction. The sensitivity of detection achieved for the pathogen was 100cells per reaction. The specificity of the primers was demonstrated by spiking the reaction with non-specifictemplate. The developed protocol was successfully extended to environmental samples.
CONCLUSIONS: Thedeveloped duplex PCR protocol allows the simultaneous detection of two genetic loci of the target pathogenfrom water samples. This enhances the efficiency of detection and provides a sensitive tool for the rapiddetection of the pathogen that can be useful in epidemic conditions where the time factor involved inthe identification of target pathogen is very crucial.
Keywords: Vibrio, PCR, Waterborne pathogens, ctxAB, tcpA
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952